IL6 and neoplasm: Activation of STAT3 by IL-6 allows expression of cell cycle-promoting proteins such as cyclin D1, D2, and c-MYC and downregulation of cyclin-dependent kinase inhibitor p21, facilitating entry into the cell cycle, thus enhancing the growth of the tumour [32,145].